We are live on ! Find out more
AI

AdvisorShares Investments Portfolio holdings

AUM $549M
1-Year Est. Return 32.58%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+32.58%
3 Year Est. Return
+93.4%
5 Year Est. Return
+34.9%
10 Year Est. Return
AUM
$574M
AUM Growth
-$19M
Cap. Flow
+$15.3M
Cap. Flow %
2.66%
Top 10 Hldgs %
54.1%
Holding
346
New
71
Increased
77
Reduced
103
Closed
73

Sector Composition

Rank Sector Weight
1 Technology 9.43%
2 Healthcare 8.14%
3 Financials 7.64%
4 Consumer Discretionary 7.32%
5 Industrials 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GHRS icon
201
GH Research
GHRS
$2.08B
$266K 0.05%
22,605
-7,458
-25% -$89.5K
TBCH
202
Turtle Beach Corp
TBCH
$277M
$262K 0.05%
18,477
-756
-4% -$11.7K
TAP icon
203
Molson Coors Class B
TAP
$8.09B
$258K 0.04%
5,094
-208
-4% -$12K
MGPI icon
204
MGP Ingredients
MGPI
$375M
$253K 0.04%
3,465
-142
-4% -$11.1K
ITCI
205
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$252K 0.04%
3,705
-870
-19% -$60.3K
NAPA
206
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$251K 0.04%
35,792
+16,536
+86% +$133K
IXHL icon
207
Incannex Healthcare
IXHL
$37.7M
$238K 0.04%
2,667
+970
+57% +$83.7K
EAT icon
208
Brinker International
EAT
$9.66B
$227K 0.04%
3,131
MAPS
209
DELISTED
WM TECHNOLOGY INC A
MAPS
$224K 0.04%
+200,000
New +$220K
CAVA icon
210
CAVA Group
CAVA
$7.27B
$224K 0.04%
2,350
INCR
211
Intercure
INCR
$58M
$218K 0.04%
+107,414
New +$292K
CMND icon
212
Clearmind Medicine
CMND
$2.42M
$214K 0.04%
322
+40
+14% +$19.3K
SKYE icon
213
Skye Bioscience
SKYE
$18.3M
$210K 0.04%
+26,000
New +$309K
TH icon
214
Target Hospitality
TH
$1.64B
$192K 0.03%
22,589
+5,624
+33% +$58.7K
DRUG
215
Bright Minds Biosciences
DRUG
$778M
$190K 0.03%
180,992
+4,954
+3% +$5.59K
ENVB icon
216
Enveric Biosciences
ENVB
$6.24M
$190K 0.03%
1,761
+434
+33% +$65.4K
EXPE icon
217
Expedia Group
EXPE
$37.3B
$186K 0.03%
1,517
+100
+7% +$12.3K
TCOM icon
218
Trip.com Group
TCOM
$29.1B
$185K 0.03%
3,896
-868
-18% -$44.2K
VTGN icon
219
VistaGen Therapeutics
VTGN
$12.8M
$185K 0.03%
51,780
-20,291
-28% -$87.9K
SAGE
220
DELISTED
Sage Therapeutics
SAGE
$177K 0.03%
16,030
+1,918
+14% +$24.6K
BROS icon
221
Dutch Bros
BROS
$9.26B
$176K 0.03%
4,210
RCL icon
222
Royal Caribbean
RCL
$85.6B
$172K 0.03%
1,100
-532
-33% -$76.5K
IHG icon
223
InterContinental Hotels
IHG
$23.2B
$164K 0.03%
1,583
+668
+73% +$67.6K
XHR
224
Xenia Hotels & Resorts
XHR
$1.79B
$164K 0.03%
+11,780
New +$170K
CMG icon
225
Chipotle Mexican Grill
CMG
$41.5B
$164K 0.03%
2,650

Similar funds

AdvisorShares Investments's Q2 2024 Portfolio in Review

As of Q2 2024, AdvisorShares Investments held 346 positions worth $574M, down 3.2% from $593M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

AdvisorShares Investments's Q2 2024 filing shows 71 new, 77 increased, 103 reduced and 73 closed positions. Its largest new stake was iShares Morningstar Growth ETF: 495,156 shares worth $40.6M. The largest sale was Invesco QQQ Trust, an estimated $37.2M.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 7.4% a quarter earlier, followed by Healthcare and Financials.

  • AdvisorShares Investments's largest Q2 2024 buy was iShares Morningstar Growth ETF: 495,156 shares worth $40.6M.
  • AdvisorShares Investments added most to Thermo Fisher Scientific in Q2 2024, an estimated $893K increase.
  • AdvisorShares Investments's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $37.2M.
  • AdvisorShares Investments fully exited State Street Consumer Staples Select Sector SPDR ETF in Q2 2024, selling an estimated $1.44M.
  • AdvisorShares Investments's ten largest holdings make up 54% of its $574M portfolio in Q2 2024.
  • AdvisorShares Investments opened 71 new positions and closed 73 in Q2 2024.
  • AdvisorShares Investments's portfolio value fell 3.2% quarter-over-quarter to $574M.

Based on AdvisorShares Investments's 13F filing for Q2 2024, filed 7 Aug 2024.